Rick Bright | |
---|---|
Director of the Biomedical Advanced R&D Authority Deputy Assistant Secretary of Health and Human Services for Preparedness and Response | |
In office November 15, 2016 – April 22, 2020 | |
President | Barack Obama Donald Trump |
Preceded by | Robin Robinson |
Succeeded by | Gary Disbrow |
Member of the COVID-19 Advisory Board | |
In office November 9, 2020–January 10, 2021 | |
Preceded by | Position established* |
Succeeded by | Position abolished* |
Personal details | |
Born | Rick Arthur Bright Hutchinson, Kansas, U.S. |
Education | University of Kansas Auburn University, Montgomery (BS) Emory University (MS, PhD) |
Scientific career | |
Fields | Immunology |
Institutions | Emory University Yerkes National Primate Research Center Novavax Biomedical Advanced Research and Development Authority |
Thesis | Studies on pathogenicity and control of H5N1 influenza A viruses in mice (2002) |
Doctoral advisor | Jacqueline Katz |
Other academic advisors | Jeff Barksdale |
Rick Arthur Bright is an American immunologist, vaccine researcher, and public health official.[1][2][3] He was the director of the Biomedical Advanced Research and Development Authority (BARDA) from 2016 to 2020. In May 2020, he filed a whistleblower complaint, alleging that the Trump administration ignored his early warnings about the COVID-19 pandemic and illegally retaliated against him by ousting him from his role[4][5][6] and demoting him to a position at the National Institutes of Health.[6] On October 6, 2020, Bright resigned from the government.[2] On November 9 he was named a member of President-elect Joe Biden's coronavirus advisory board.[7]
Mucha
was invoked but never defined (see the help page).